Natalizumab induced cutaneous sarcoidosis-like reaction
We present a case of a drug-induced sarcoidosis -like reaction (DISR) occurring following initiation of Natalizumab for multiple sclerosis. The reaction was purely cutaneous, and disappeared following drug withdrawal. We highlight this case to the practicing neurologists, with warning to be wary of a new rash on immunomodulatory therapies.
Source: Journal of Neuroimmunology - Category: Allergy & Immunology Authors: R. Durcan, C. Heffron, B. Sweeney Tags: Short Communication Source Type: research
More News: Allergy & Immunology | Brain | Multiple Sclerosis | Neurology | Sarcoidosis | Tysabri | Warnings